Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.

Authors

Brian Claggett
John M Lachin, George Washington University
Stefan Hantel
David Fitchett
Silvio E Inzucchi
Hans J Woerle
Jyothis T George
Bernard Zinman

Document Type

Journal Article

Publication Date

10-9-2018

Journal

Circulation

Volume

138

Issue

15

Inclusive Pages

1599-1601

DOI

10.1161/CIRCULATIONAHA.118.033810

APA Citation

Claggett, B., Lachin, J., Hantel, S., Fitchett, D., Inzucchi, S., Woerle, H., George, J., & Zinman, B. (2018). Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.. Circulation, 138 (15). http://dx.doi.org/10.1161/CIRCULATIONAHA.118.033810